Impact of environmental factors on efficacy of glucocorticoids in chinese population with systemic lupus erythematosus

Inflammation

Volumn 36, Issue 6, 2013, Pages 1424-1430

  Zou, Yan Feng ^a   Xu, Jian Hua ^a   Tao, Jin Hui ^a   Xu, Sheng Qian ^a   Liu, Shuang ^a   Chen, Shan Yu ^a   Cai, Jing ^a   Lian, Li ^a   Chen, Pei Ling ^a   Wang, De Guang ^a   Liu, Sheng Xiu ^a   Liang, Chun Mei ^a   Ye, Qian Ling ^a   Tian, Guo ^a   Wu, Min ^a   Pan, Hai Feng ^a   Pan, Fa Ming ^a   Su, Hong ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

efficacy; environmental factors; glucocorticoids; systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID; PREDNISONE;

ADULT; ALLERGY; ARTICLE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; HUMAN; INTROVERSION; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SALT INTAKE; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CHINA; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERSENSITIVITY; LIFE CHANGE EVENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PERSONALITY; PREDNISONE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SODIUM CHLORIDE;

EID: 84888201656     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9682-3     Document Type: Article

References (23)

1. Mosca, M., C. Tani, L. Carli, and S. Bombardieri. 2011. Glucocorticoids in systemic lupus erythematosus. Clinical and Experimental Rheumatology 29: S126-S129.
2. van Rossum, E.F., and E.L. van den Akker. 2011. Glucocorticoid resistance. Endocrine Development 20: 127-136.
3. Pollard, K.M., D.L. Pearson, P. Hultman, T.N. Deane, U. Lindh, and D.H. Kono. 2001. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice. Environmental Health Perspectives 109: 27-33.
4. Cooper, G.S., J. Wither, S. Bernatsky, J.O. Claudio, A. Clarke, J.D. Rioux, CaNIOS GenES Investigators, and P.R. Fortin. 2010. Occupational and environmental exposures and risk of systemic lupus erythematosus: Silica, sunlight, solvents. Rheumatology (Oxford) 49: 2172-2180.
5. Dooley, M.A., and S.L. Hogan. 2003. Environmental epidemiology and risk factors for autoimmune disease. Current Opinion in Rheumatology 15: 99-103.
6. Carnegie, S.D., L.M. Fedigan, and T.E. Ziegler. 2011. Social and environmental factors affecting fecal glucocorticoids in wild, female white-faced capuchins (Cebus capucinus). American Journal of Primatology 73: 861-869.
7. Odermatt, A., and C. Gumy. 2008. Glucocorticoid and mineralocorticoid action: Why should we consider influences by environmental chemicals? Biochemical Pharmacology 76: 1184-1193.
8. Hochberg, M.C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 40: 1725.
9. Costedoat-Chalumeau, N., G. Leroux, J.C. Piette, and Z. Amoura. 2010. Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment? Joint Bone Spine 77: 4-5.
10. Borchers, A.T., C.L. Keen, Y. Shoenfeld, and M.E. Gershwin. 2004. Surviving the butterfly and the wolf: Mortality trends in systemic lupus erythematosus. Autoimmunity Reviews 3: 423-53.
11. Cronstein, B.N. 2006. Pharmacogenetics in the rheumatic diseases. Bulletin of the NYU Hospital for Joint Diseases 64: 16-19.
12. Drake, S.L., K. Lopetcharat, and M.A. Drake. 2011. Salty taste in dairy foods: Can we reduce the salt? Journal of Dairy Science 94: 636-645.
13. Contreras, R.J. 1978. Salt taste and disease. American Journal of Clinical Nutrition 31: 1088-1097.
14. Mattes, R.D. 1984. Salt taste and hypertension: A critical review of the literature. Journal Chronic Disease 37: 195-208.
15. Kleinewietfeld, M., A. Manzel, J. Titze, H. Kvakan, N. Yosef, R.A. Linker, D.N. Muller, and D.A. Hafler. 2013. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496: 518-522.
16. Paterniti, S., I. Niedhammer, T. Lang, and S.M. Consoli. 2002. Psychosocial factors at work, personality traits and depressive symptoms. Longitudinal results from the GAZEL Study. British Journal of Psychiatry 181: 111-117.
17. Dalgard, O.S., S. Bjørk, and K. Tambs. 1995. Social support, negative life events and mental health. British Journal of Psychiatry 166: 29-34.
18. Marian, G., E.A. Nica, B.E. Ionescu, and D.G. Carlogea. 2010. Depression as an initial feature of systemic lupus erythematosus? A case report. Journal Medicine Life 3: 183-185.
19. Millar, K., S.M. Lloyd, J.S. McLean, G.D. Batty, H. Burns, J. Cavanagh, K.A. Deans, I. Ford, A. McConnachie, A. McGinty, R. Mõttus, C.J. Packard, N. Sattar, P.G. Shiels, Y.N. Velupillai, and C. Tannahill. 2013. Personality, socio-economic status and inflammation: Cross-sectional, population-based study. PLoS One 8: e58256.
20. Zozulya, A.A., M.V. Gabaeva, O.Y. Sokolov, I.D. Surkina, and N.V. Kost. 2008. Personality, coping style, and constitutional neuroimmunology. Journal of Immunotoxicology 5: 221-225.
21. Howland, L.C., S.L. Gortmaker, L.M. Mofenson, C. Spino, J.D. Gardner, H. Gorski, M.G. Fowler, and J. Oleske. 2000. Effects of negative life events on immune suppression in children and youth infected with human immunodeficiency virus type 1. Pediatrics 106: 540-546.
22. Kay, A.B. 2000. Overview of 'Allergy and allergic diseases: with a view to the future'. British Medical Bulletin 56: 843-864.
23. Carmichael, S.J., B. Charles, and S.E. Tett. 2003. Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Therapeutic Drug Monitoring. 25: 671-681.